Jubiliant Life gets ANDA approval for its hypertension drug
Jubiliant Life Sciences Ltd has received the final Abbreviated New Drug Application (ANDA) approval for its drug Olmesartan Medoxomil, the […]
ABBREVIATED-NEW-DRUG-APPLICATION
Jubiliant Life Sciences Ltd has received the final Abbreviated New Drug Application (ANDA) approval for its drug Olmesartan Medoxomil, the […]
